HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2009.124172v1 55/5/848    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Klee, G. G. Search for Related Content PubMed PubMed Citation Articles by Klee, G. G.

Assay Configuration and Analytic Specificity May Have Major Effects on Prediction of Clinical Outcomes— Implications for Reference Standards

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

^aAddress correspondence to the author at: 200 First St. S.W., Rochester, MN 55905. Fax (507) 266-5193; e-mail klee.george@mayo.edu.

The first 20% of the full text of this article appears below.

In this month’s issue of Clinical Chemistry, Anborgh et al. demonstrate that differences in assay configuration can produce major differences in the association of plasma osteopontin measurements with survival in prostate cancer (1). Prediction of survival was found to be significantly better with assays that have a monoclonal antibody targeted to a specific epitope on the osteopontin molecule. This linkage between assay configuration and clinical utility may have major implications on the way reference materials and reference methods are formulated, because, as this report shows, the reference standards may need to focus on specific forms of the analyte.

Various national and international organizations are working to develop reference standards to help harmonize diagnostic assays. The European Union In Vitro Diagnostics Directive (98/79/EC) requires manufacturers marketing in the European Union to provide evidence that the values assigned to calibrators and control materials are traceable, through available reference measurement procedures and reference materials (when available), to standards of a higher metrological order (2)(3). The Joint Committee on Traceability in Laboratory Medicine (JCTLM)¹ has helped guide the logistics of traceability with the use of European Committee for Standardization (CEN) and International Organization for Standardization (ISO) standards (4). ISO document 17511 . . . [Full Text of this Article]